Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 572

1.
2.

Donor selection for KIR B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation.

Zhou H, Bao X, Wu X, Tang X, Wang M, Wu D, He J.

Biol Blood Marrow Transplant. 2013 Oct 25. pii: S1083-8791(13)00494-1. doi: 10.1016/j.bbmt.2013.10.017. [Epub ahead of print]

PMID:
24513672
3.
4.

The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings.

Clausen J, Kircher B, Auberger J, Schumacher P, Ulmer H, Hetzenauer G, Wolf D, Gastl G, Nachbaur D.

Biol Blood Marrow Transplant. 2010 Feb;16(2):273-80. doi: 10.1016/j.bbmt.2009.10.021. Epub 2009 Oct 24.

6.

Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation.

Symons HJ, Leffell MS, Rossiter ND, Zahurak M, Jones RJ, Fuchs EJ.

Biol Blood Marrow Transplant. 2010 Apr;16(4):533-42. doi: 10.1016/j.bbmt.2009.11.022. Epub 2009 Dec 2.

7.

Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.

Faridi RM, Kemp TJ, Dharmani-Khan P, Lewis V, Tripathi G, Rajalingam R, Daly A, Berka N, Storek J, Masood Khan F.

PLoS One. 2016 Jun 24;11(6):e0158242. doi: 10.1371/journal.pone.0158242. eCollection 2016.

8.

Donor KIR Genes 2DL5A, 2DS1 and 3DS1 are associated with a reduced rate of leukemia relapse after HLA-identical sibling stem cell transplantation for acute myeloid leukemia but not other hematologic malignancies.

Stringaris K, Adams S, Uribe M, Eniafe R, Wu CO, Savani BN, Barrett AJ.

Biol Blood Marrow Transplant. 2010 Sep;16(9):1257-64. doi: 10.1016/j.bbmt.2010.03.004. Epub 2010 Mar 17.

9.

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

Cooley S, Trachtenberg E, Bergemann TL, Saeteurn K, Klein J, Le CT, Marsh SG, Guethlein LA, Parham P, Miller JS, Weisdorf DJ.

Blood. 2009 Jan 15;113(3):726-32. doi: 10.1182/blood-2008-07-171926. Epub 2008 Oct 22.

10.
11.

Role of killer immunoglobulin-like receptor-ligand interactions in human leukocyte antigen-matched sibling hematopoietic stem cell transplantation.

Kanga U, Mourya M, Seth T, George J, Sood P, Sharma R, Saxena A, Mehra NK.

Transplant Proc. 2012 May;44(4):919-21. doi: 10.1016/j.transproceed.2012.03.036.

PMID:
22564585
13.

[Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].

Dou LP, DA WM, Zhao DD, Wang C, Lu XC, Kang HY, Yan P, Wang FF, Zhu HY, Li HH, Gao CJ, Yu L.

Zhonghua Yi Xue Za Zhi. 2007 Nov 27;87(44):3111-4. Chinese.

PMID:
18269867
14.

KIR2DS4 and Its Variant KIR1D Are Associated with Acute Graft-versus-Host Disease, Cytomegalovirus, and Overall Survival after Sibling-Related HLA-Matched Transplantation in Patients with Donors with KIR Gene Haplotype A.

Wu X, Yao Y, Bao X, Zhou H, Tang X, Han Y, Ma X, Liu Y, Chen J, Zhou H, Jing S, Gu B, Xu Y, Sun A, He J, Wu D.

Biol Blood Marrow Transplant. 2016 Feb;22(2):220-225. doi: 10.1016/j.bbmt.2015.10.004. Epub 2015 Oct 22.

15.

[Relationship between the genetic background of donor KIR recipient HLA and the outcomes in HLA-identical sibling HSCT].

Ma HJ, Yin XL, Guo KY, Xiao LL, Ye X.

Zhonghua Xue Ye Xue Za Zhi. 2006 Feb;27(2):91-4. Chinese.

PMID:
16732960
16.

The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.

Wu GQ, Zhao YM, Lai XY, Luo Y, Tan YM, Shi JM, Li L, Zheng WY, Zhang J, Hu XR, Jin AY, He JS, Xie WZ, Ye XJ, Cai Z, Lin MF, Huang H.

Bone Marrow Transplant. 2010 Oct;45(10):1514-21. doi: 10.1038/bmt.2010.3. Epub 2010 Feb 22.

PMID:
20173784
17.

Analysis of KIR genes in HLA-identical sibling hematopoietic stem cell transplantation in Thai patients with leukemia.

Wongwuttisaroj N, Vejbaesya S, Chongkolwatana V, Issaragrisil S.

J Med Assoc Thai. 2012 Oct;95(10):1261-5.

PMID:
23193738
18.

Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.

Gagne K, Busson M, Bignon JD, Balère-Appert ML, Loiseau P, Dormoy A, Dubois V, Perrier P, Jollet I, Bois M, Masson D, Moine A, Absi L, Blaise D, Charron D, Raffoux C; ARS2000 FRM and FGM group.

Biol Blood Marrow Transplant. 2009 Nov;15(11):1366-75. doi: 10.1016/j.bbmt.2009.06.015.

19.

[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].

Wang H, Zhai WJ, Wang HH, He Y, Zhou Z, Zhao YX, Zhai WH, Zhang RL, Wang M, Feng SZ, Han MZ.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2009 Oct;31(5):533-7. Chinese.

20.

KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.

Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon JD, Bornhäuser M, Christiansen F, Gratwohl A, Morishima Y, Oudshoorn M, Ringden O, van Rood JJ, Petersdorf E; International Histocompatibility Working Group.

Biol Blood Marrow Transplant. 2006 Aug;12(8):828-36.

Supplemental Content

Support Center